News

Weight-loss jabs could help minimise asthma symptoms in obese people, according to a study. The drugs should be explored as a ...
Researchers says the drugs could be a treatment for obese people with asthma who are ‘often resistant’ to steroids ...
For older patients with cancer and type 2 diabetes (T2D), glucagon-like peptide-1 receptor agonist (GLP-1 RA) use is ...
GLP-1 drugs like Ozempic have already become a game-changer for obesity and diabetes. But new research shows they may also ...
Many people stop taking GLP-1 drugs like Ozempic within a year, but doing so often leads to weight regain. Here's what to know before stopping.
Eating disorder centers are facing an influx of people with weight-loss prescriptions. Experts say doctors are ...
What happens when you stop taking Ozempic®? There’s no one-size-fits-all answer to this question. When you stop taking ...
Guidelines for pregnancy care in individuals with preexisting diabetes mellitus include stopping GLP-1 RA use and avoiding metformin.
For older adults with diabetes, there is no clear evidence to suggest that the incidence of dementia differs for those using GLP-1 RAs vs DPP4is.
Lupin has received USFDA approval for generic diabetes medications, specifically Liraglutide Injection and Glucagon for ...